TLIS

Talis Biomedical Corporation

9.30 USD
+0.17 (+1.86%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Talis Biomedical Corporation stock is up 2.54% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 May’s closed higher than April.

About Talis Biomedical Corporation

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis 1 COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVI-19.